Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency

HIGHLIGHTS

• who: Yutaka Takahashi from the Department of Diabetes and Endocrinology, Nara Medical University, Shijou2011Cho, Kashihara, Nara, u20118522, Japan have published the paper: Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency, in the Journal: (JOURNAL)
• how: In post hoc-defined analyses the authors compared the effects of somapacitan with daily (GH) and placebo on fasting plasma glucose (FPG) glycated hemoglobin (HbA1c) fasting insulin homeostasis model assessment of insulin resistance (HOMA-IR) and beta-cell function (HOMA-u03b2) in patients with AGHD across a unique data set from three phase . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.